Clinical and research tests for 1806 - Genetic Testing Registry (GTR)

<< First< Prev

Page 1 of 4

Results: 1 to 20 of 71

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
SmartMeds+ Pharmacogenomic Testing By Innovative GX Health Innovative Genomics InnovativeGx Health United States	1	67	T Targeted variant analysis
Precision HealthPGx Panel (25 Genes) RPRD Diagnostics, LLC United States	97	23	D Deletion/duplication analysis T Targeted variant analysis
Whole Pharmacogenomics Scan RPRD Diagnostics, LLC United States	107	69	D Deletion/duplication analysis T Targeted variant analysis
DPYD Full Gene Sequencing Mayo Clinic Laboratories Mayo Clinic United States	4	1	C Sequence analysis of the entire coding region
EpiPanelDx PLUS Genetic Test Bionano Laboratories United States	3	244	E Sequence analysis of select exons
Tempus xT Tempus Labs, Inc. United States	2	647	I Microsatellite instability testing (MSI) C Sequence analysis of the entire coding region
CentoMetabolic MOx Centogene US, LLC - The Rare Disease Company United States	195	221	A Analyte D Deletion/duplication analysis C Sequence analysis of the entire coding region
DPYD - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States	1	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CentoScreen Centogene US, LLC - The Rare Disease Company United States	316	314	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
CentoICU Panel Centogene US, LLC - The Rare Disease Company United States	829	848	C Sequence analysis of the entire coding region
CentoIEM Panel Centogene US, LLC - The Rare Disease Company United States	669	688	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CentoNeuro Panel Centogene US, LLC - The Rare Disease Company United States	1886	1858	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Epilepsy Panel Centogene US, LLC - The Rare Disease Company United States	734	744	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Intellectual Disability Panel Centogene US, LLC - The Rare Disease Company United States	777	770	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Carrier Screening Guidelines-Based Panel Ambry Genetics United States	199	165	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Pharmacogenomics Panel Invitae United States	43	37	T Targeted variant analysis
Pharmacogenomics SNaP-Shot Ariel Precision Medicine United States	1	26	T Targeted variant analysis
DPYD Invitae United States	1	1	T Targeted variant analysis
Polypharmacy Comprehensive Panel Invitae United States	33	24	D Deletion/duplication analysis T Targeted variant analysis
RxMatch Intermountain Healthcare Precision Genomics Intermountain Health United States	2	23	E Sequence analysis of select exons

<< First< Prev

Page 1 of 4

Next >Last >>

Results: 1 to 20 of 71

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Filters

Test type

Test purpose

Test method

Biochemical Genetics

Molecular Genetics

Test service

Laboratory certification

Specimen type

Laboratory location

Other countries

Results: 1 to 20 of 71

Results: 1 to 20 of 71